Structural and functional effects of metastases in rat brain determined by multimodal MRI
Sébastien Serres1, Christopher J Martin, Manuel Sarmiento Soto
1CR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, United Kingdom.
Abstract:
Metastasis to the brain results in significant impairment of brain function and poor patient survival. Currently, magnetic resonance imaging (MRI) is under-utilised in monitoring brain metastases and their effects on brain function. Here, we sought to establish a model of focal brain metastasis in the rat that enables serial multimodal structural and functional MRI studies, and to assess the sensitivity of these approaches to metastatic growth. Female Berlin-Druckrey-IX rats were injected intracerebrally with metastatic ENU1564 cells in the ventroposterior medial nucleus (VPM) of the thalamus, a relay node of the whisker-to-barrel cortex pathway. Animals underwent multimodal structural and vascular MRI, as well as functional MRI of the cortical blood oxygenation level dependent (BOLD) responses to whisker pad stimulation. T2 , diffusion, magnetisation transfer and perfusion weighted MRI enabled differentiation between a central area of more advanced metastatic growth and penumbral regions of co-optive perivascular micrometastatic growth, with magnetisation transfer MRI being the most sensitive to micrometastatic growth. Areas of cortical BOLD activation in response to whisker pad stimulation were significantly reduced in the hemisphere containing metastases in the VPM. The reduction in BOLD response correlated with metastatic burden in the thalamus, and was sensitive to the presence of smaller metastases than currently detectable clinically. Our findings suggest that multimodal MRI provides greater sensitivity to tumour heterogeneity and micrometastatic growth than single modality contrast-enhanced MRI. Understanding the relationships between these MRI parameters and the underlying pathology may greatly enhance the utility of MRI in diagnosis, staging and monitoring of brain metastasis.
Insights
Multimodal magnetic resonance imaging (MRI) offers enhanced sensitivity for detecting brain metastases and their functional impact. This advanced MRI approach can identify micrometastatic growth and changes in brain function earlier than current clinical methods.
Area of Science:
- Neuroscience
- Oncology
- Medical Imaging
Background:
- Brain metastases significantly impair function and reduce survival.
- Current magnetic resonance imaging (MRI) underutilizes its potential for monitoring brain metastases.
- A need exists for sensitive imaging techniques to detect early metastatic growth and functional changes.
Purpose of the Study:
- To develop a rat model for studying focal brain metastasis using serial multimodal MRI.
- To assess the sensitivity of various MRI techniques to metastatic growth and its effects on brain function.
- To compare the sensitivity of multimodal MRI with contrast-enhanced MRI for detecting tumor heterogeneity.
Main Methods:
- Established a focal brain metastasis model in rats by intracerebral injection of ENU1564 cells into the thalamus.
- Utilized multimodal structural, vascular, and functional MRI, including blood oxygenation level dependent (BOLD) responses to whisker stimulation.
- Employed T2, diffusion, magnetization transfer (MT), and perfusion-weighted MRI sequences.
Main Results:
- Magnetization transfer MRI demonstrated the highest sensitivity to micrometastatic growth.
- Reduced cortical BOLD activation was observed in hemispheres with VPM metastases, correlating with metastatic burden.
- Multimodal MRI detected smaller metastases and greater tumor heterogeneity than single-modality contrast-enhanced MRI.
Conclusions:
- Multimodal MRI surpasses single-modality contrast-enhanced MRI in sensitivity to tumor heterogeneity and micrometastatic growth.
- The developed rat model facilitates serial multimodal MRI studies of brain metastasis.
- Further understanding of MRI parameters and pathology can improve diagnosis, staging, and monitoring of brain metastases.


